Inhibitory effects of alpha-carotene on proliferation of the human neuroblastoma cell line GOTO. 1989

M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
Department of Biochemistry, Kyoto Prefectural University of Medicine, Japan.

alpha-Carotene inhibited the proliferation of the human neuroblastoma cell line GOTO in a dose- and time-dependent manner. In addition, it was about 10 times more inhibitory than beta-carotene. Northern blot analysis indicated that alpha-carotene caused maximum suppression of the level of the N-myc messenger RNA of GOTO cells. This suppression occurred within 18 hours of alpha-carotene treatment, after which the level of the N-myc messenger RNA gradually recovered to the basal level. Analysis by flow cytometry indicated that when GOTO cells were exposed to alpha-carotene, they were arrested in the G0-G1 phase of their cell cycle. However, as the level of the N-myc messenger RNA was recovering, these cells resumed normal cycling. These results indicate that the reduction in the level of the N-myc messenger RNA caused by alpha-carotene is closely linked with G0-G1 arrest.

UI MeSH Term Description Entries
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002338 Carotenoids The general name for a group of fat-soluble pigments found in green, yellow, and leafy vegetables, and yellow fruits. They are aliphatic hydrocarbons containing 4 terpene subunits. Carotenes,Carotenoid,Tetraterpene Derivatives,Tetraterpenes,Carotene,Derivatives, Tetraterpene
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D019207 beta Carotene A carotenoid that is a precursor of VITAMIN A. Beta carotene is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC). Betacarotene,BellaCarotin,Carotaben,Max-Caro,Provatene,Solatene,Vetoron,beta-Carotene,Carotene, beta,Max Caro,MaxCaro

Related Publications

M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
July 2001, Wei sheng yan jiu = Journal of hygiene research,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
May 1994, Biological psychiatry,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
September 1996, Toxicology and applied pharmacology,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
August 2011, Zhonghua yi xue za zhi,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
January 1993, Brain research. Molecular brain research,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
September 1983, Cancer research,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
February 2015, Oncology letters,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
October 2013, Oncology letters,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
October 2011, Molecular biology reports,
M Murakoshi, and J Takayasu, and O Kimura, and E Kohmura, and H Nishino, and A Iwashima, and J Okuzumi, and T Sakai, and T Sugimoto, and J Imanishi
April 2006, Ai zheng = Aizheng = Chinese journal of cancer,
Copied contents to your clipboard!